Michihiko Wada

Prepare for Meeting →

Chief Regulatory and Development Officer

Newton Biocapital

Check size: Newton Biocapital does not publish a standard current check-size range on its official site.

Investment Thesis

Michihiko Wada is listed in a Chief Regulatory and Development Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

What Excites Them

Strong science, experienced teams and differentiated healthcare products with credible development and internationalization paths.

What They Pass On

Opportunities outside life sciences or without evidence of unmet need, differentiation and development feasibility are less aligned.

How to Pitch

Present the unmet need, evidence, intellectual property, regulatory and clinical plan, team and Europe-Japan opportunity.

Notable Writing

No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.

Podcast Appearances

No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.

Key Quotes

Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.

Background

Michihiko Wada is a current Chief Regulatory and Development Officer at Newton Biocapital, according to the firm's official roster. No additional background is inferred where the firm does not publish a biography.

Share
Requests are processed by our agent pipeline nightlyIs this you? Request removal